Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,394,010
-$262,344 QoQ
Shares Held
466,456
-18.5% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. NVAX ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,394,010 | 466,456 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,656,354 | 572,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,984,849 | 3,717,984 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,332,766 | 1,076,444 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,804,349 | 1,238,786 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $12,678,590 | 1,977,940 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,718,521 | 4,940,115 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $19,604,522 | 1,552,219 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $21,556,621 | 1,702,735 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $8,940,174 | 1,870,330 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $34,758,981 | 7,241,455 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $16,471,944 | 2,275,131 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $15,457,642 | 2,080,437 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,005,100 | 2,453,839 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,292,167 | 1,779,394 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,914,073 | 1,094,180 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,148,697 | 1,286,189 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $66,489,302 | 902,774 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $136,845,308 | 956,492 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $142,136,706 | 685,624 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $99,823,062 | 470,176 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $52,063,527 | 287,152 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $38,870,489 | 348,583 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $50,274,181 | 463,998 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $20,745,397 | 248,895 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,927,275 | 436,471 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||